Free Access
Med Sci (Paris)
Volume 20, Number 5, Mai 2004
Page(s) 516 - 518
Section Nouvelles
Published online 15 May 2004
  1. Cooksey CJ. Tyrian purple : 6,6’-dibromoindigo and related compounds. Molecules 2001; 6 : 736–69. [Google Scholar]
  2. Friedlander P. Uber den Farstoff des antikeen Purpurs aus Murex brandaris. 1909; 765–70. [Google Scholar]
  3. Balfour-Paul J. Indigo. British Museum Press. 1998 : 264 p. [Google Scholar]
  4. Hoessel R, Leclerc S, Endicott J, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999; 1 : 60–7. [Google Scholar]
  5. Damiens E, Baratte B, Marie D, et al. Anti-mitotic properties of indirubin-3’-monoxime, a CDK/GSK-3 inhibitor : induction of endoreplication following prophase arrest. Oncogene 2001; 20 : 3786–97. [Google Scholar]
  6. Davies TG, Tunnah P, Meijer L, et al. Inhibitor binding to active and inactive CDK2. The crystal structure of a CDK2-cyclin A/indirubin-5-sulphonate. Structure 2001; 9 : 389–97. [Google Scholar]
  7. Holton S, Merckx A, Burgess D, et al. Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition. Structure 2003; 11 : 1329–37. [Google Scholar]
  8. Leclerc S, Garnier M, Hoessel R, et al. Indirubins inhibit glycogen synthase kinase-3béta and CDK5/p25, two kinases involved in abnormal tau phosphorylation in Alzheimer’s disease - a property common to most CDK inhibitors ? J Biol Chem 2001; 276 : 251–60. [Google Scholar]
  9. Meijer L, Skaltsounis AL, Magiatis P, et al. GSK-3 selective inhibitors derived from Tyrian purple indirubins. Chem Biol 2003; 10 : 1255–66. [Google Scholar]
  10. Polychronopoulos P, Magiatis P, Skaltsounis L, et al. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. J Med Chem 2004; 47 : 935–46. [Google Scholar]
  11. Fischer PM. CDK versus GSK-3 inhibition : a purple haze no longer ? Chem Biol 2003; 10 : 1144–6. [Google Scholar]
  12. Sato N, Meijer L, Skaltsounis L, et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3 specific inhibitor. Nat Med 2004; 10 : 55–63. [Google Scholar]
  13. Dolique R. Balard, sa vie, son œuvre à Montpellier de 1802 à 1840. Rev Hist Pharm 1977; 232 : 13–27. [Google Scholar]
  14. Lacaze-Duthiers H. Mémoire sur la Pourpre. An Sci Nat Zool 1859; 12 : 5–84. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.